Medtronic
MDT | NYSE
$96.54
-$0.57 (-0.59%)
At close: Oct 30, 2026, 4:00 PM ET
$96.44
-$0.10 (-0.10%)
Pre-market:
Nov 2, 2026, 4:03 AM ET
Fiscal Year Period Ending | FY 2026 Apr 24, 2026 | FY 2025 Apr 25, 2025 | FY 2024 Apr 26, 2024 | FY 2023 Apr 28, 2023 | FY 2022 Apr 29, 2022 | FY 2021 Apr 30, 2021 |
|---|---|---|---|---|---|---|
Revenue | 36.36B | 33.54B | 32.36B | 31.23B | 31.69B | 30.12B |
Cost of Revenue | 12.72B | 11.63B | 11.22B | 10.72B | 10.15B | 10.48B |
Gross Profit | 23.64B | 21.91B | 21.15B | 20.51B | 21.54B | 19.63B |
Operating Income | 6.47B | 5.96B | 5.14B | 5.49B | 5.75B | 4.48B |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 6.14B | 5.63B | 4.84B | 5.36B | 5.52B | 3.9B |
Net Income | 4.8B | 4.66B | 3.68B | 3.76B | 5.04B | 3.61B |
Selling & General & Admin | 11.78B | 10.85B | 10.74B | 10.42B | 10.29B | 10.15B |
Research & Development | 2.87B | 2.73B | 2.74B | 2.7B | 2.75B | 2.49B |
Other Expenses | 2.52B | 2.37B | 2.53B | 1.91B | 2.75B | 2.51B |
Operating Expenses | 17.18B | 15.95B | 16B | 15.02B | 15.79B | 15.15B |
Interest Expense | 715M | 729M | 719M | 636M | 553M | 925M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 29.9B | 27.58B | 27.22B | 25.74B | 25.93B | 25.63B |
Income Tax Expense | 1.3B | 936M | 1.13B | 1.58B | 456M | 265M |
Shares Outstanding (Basic) | 1.28B | 1.29B | 1.33B | 1.33B | 1.34B | 1.34B |
Shares Outstanding (Diluted) | 1.29B | 1.29B | 1.33B | 1.33B | 1.35B | 1.35B |
EPS (Basic) | 3.75 | 3.63 | 2.77 | 2.83 | 3.75 | 2.68 |
EPS (Diluted) | 3.73 | 3.61 | 2.76 | 2.82 | 3.73 | 2.66 |
EBITDA | 9.81B | 9.22B | 8.2B | 8.7B | 8.78B | 7.52B |
EBIT | 6.85B | 6.36B | 5.56B | 6B | 6.07B | 4.82B |
Depreciation & Amortization | 2.96B | 2.86B | 2.65B | 2.7B | 2.71B | 2.7B |
Add to Watchlist
Select watchlists to add or remove MDT